Results 121 to 130 of about 19,858 (239)

Efficacy and safety of biologics, multitarget therapy, and standard therapy for lupus nephritis: a systematic review and network meta-analysis

open access: yesRenal Failure
Objective This study aimed to compare the efficacy and safety of biologics, multitarget therapy, and standard therapy for the induction of lupus nephritis.Methods A systematic search of electronic databases (EMBASE, Web of Science, PubMed, Cochrane ...
Gui-Qing Tian, Zhen-Qiong Li
doaj   +1 more source

multitarget drug discovery

open access: yes
Citation: 'multitarget drug discovery' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.12688 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Supplemental Figure 3 from A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

open access: gold, 2023
Thomas J. Galloway   +12 more
openalex   +1 more source

Multitarget Bistatic MIMO RADAR

open access: yes
10 pages, 10 ...
Dar, Nadeem, Manikas, Athanassios
openaire   +2 more sources

Doxorubicin-antioxidant multitarget drugs

open access: yes, 2013
Doxorubicin-antioxidant multitarget compounds 6 and 7 were obtained by combining doxorubicin (DOX) with caffeic and ferulic acids through an ester linkage at C-14. The products were studied in in vitro models of cardiomyocytes and breast cancer cells, characterized by different degrees of resistance to DOX, due to different expressions of ATP binding ...
CHEGAEV, Konstantin   +8 more
openaire   +1 more source

Home - About - Disclaimer - Privacy